12:00 AM
 | 
Aug 19, 2013
 |  BC Week In Review  |  Company News  |  Deals

Arthrex Inc., Cytomedix deal

Cytomedix granted orthopedic device company Arthrex exclusive, worldwide development and commercialization rights to Cytomedix's Angel Concentrated Platelet Rich Plasma System for five years, with a three year renewal...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >